OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
84
Results
Show all
Save search
Copy query
Show results for
Unknown
(84)
Publication Date
Release Date
2018
(31)
2021
(14)
2024
(6)
2022
(6)
2020
(5)
2023
(4)
2015
(4)
2014
(3)
2013
(3)
2012
(2)
2026
(1)
2019
(1)
2017
(1)
2016
(1)
2011
(1)
2010
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.
Not available
S-EPMC3549600
|
biostudies-literature
Cite
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Not available
S-EPMC4264590
|
biostudies-literature
Cite
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
Not available
S-EPMC8360701
|
biostudies-literature
Cite
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Not available
S-EPMC8446717
|
biostudies-literature
Cite
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment.
Not available
S-EPMC7390452
|
biostudies-literature
Cite
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.
Not available
S-EPMC5411393
|
biostudies-literature
Cite
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.
Not available
S-EPMC10651917
|
biostudies-literature
Cite
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
Not available
S-EPMC7243036
|
biostudies-literature
Cite
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Not available
S-EPMC8993491
|
biostudies-literature
Cite
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Not available
S-EPMC10116128
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets